Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethics review of digital health research: Rethinking rights of participants.

Perspectives in clinical research·2026
Same author

Clinical research in pediatric population: Scientific and ethical aspects.

Perspectives in clinical research·2026
Same author

Renaissance of Phase I trials in India: Lessons from global trials and tribulations of TGN1412.

Perspectives in clinical research·2026
Same author

Molecular docking and simulation analysis of nimbolide with poly-galacturonase from <i>Aspergillus niger</i>: Managing black mold disease for <i>Allium cepa</i>.

Bioinformation·2025
Same author

Applied intelligence in clinical drug development: Potential benefits and emerging concerns.

Perspectives in clinical research·2025
Same author

Clinical trial transparency and trust: Bridging the gap between data and disclosure.

Perspectives in clinical research·2025

Related Experiment Video

Updated: Feb 19, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K

International Council for Harmonisation E6(R2) addendum: Challenges of implementation.

Arun Bhatt1

  • 1Consultant - Clinical Research and Development, Mumbai, Maharashtra, India.

Perspectives in Clinical Research
|November 8, 2017
PubMed
Summary

The 2016 International Council for Harmonisation E6 (Good Clinical Practice) guideline addendum promotes quality management and risk-based monitoring in clinical trials. This article explores the challenges stakeholders face in adopting these crucial updates for enhanced human subject protection and data integrity.

Keywords:
AddendumInternational Council for Harmonisationinvestigatorregulatorysponsor

More Related Videos

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

5.0K
Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

8.8K

Related Experiment Videos

Last Updated: Feb 19, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K
Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum
04:36

Setup and Execution of the Rapid Cycle Deliberate Practice Death Notification Curriculum

Published on: August 5, 2020

5.0K
Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids
13:05

Enzymatic Synthesis of Epoxidized Metabolites of Docosahexaenoic, Eicosapentaenoic, and Arachidonic Acids

Published on: June 28, 2019

8.8K

Area of Science:

  • Clinical trial management
  • Regulatory science
  • Pharmaceutical research

Background:

  • The International Council for Harmonisation (ICH) E6 (Good Clinical Practice - GCP) guideline was updated in 2016 (R2 addendum).
  • The update aimed to integrate improved approaches for clinical trial management.
  • Key changes focus on quality management, risk-based monitoring, and data integrity.

Purpose of the Study:

  • To discuss the implementation of the ICH GCP (R2) addendum.
  • To identify challenges faced by clinical trial stakeholders in adopting the new guidelines.
  • To highlight the importance of human subject protection and data integrity in modern clinical trials.

Main Methods:

  • Review of the ICH GCP (R2) addendum.
  • Analysis of changes introduced in the guideline.
  • Discussion of adoption and implementation challenges for stakeholders.

Main Results:

  • The ICH GCP (R2) addendum introduces significant changes in clinical trial management.
  • Key areas of focus include quality management systems and risk-based monitoring.
  • Stakeholders encounter challenges in the practical adoption and implementation of these updated requirements.

Conclusions:

  • Successful adoption of the ICH GCP (R2) addendum is crucial for advancing clinical trial quality.
  • Addressing implementation challenges is necessary to fully realize benefits like enhanced human subject protection and data integrity.
  • Continuous adaptation and collaboration among stakeholders are vital for effective clinical trial oversight.